Skip to main content

and
  1. No Access

    Chapter

    Design and Assembly of Efficient Component-Based Off-Earth Infrastructure: From Vernacular to Contemporary Form-Finding Methods

    Off-Earth infrastructure has fascinated humanity for decades. This gave rise to a wealth of research and development in relation to structures and systems that can support life outside our planet. Currently, e...

    M. Konstantatou, L. Todisco, C. Borg, D. Piker in Adaptive On- and Off-Earth Environments (2024)

  2. Article

    Open Access

    First-line trifluridine/tipiracil + bevacizumab in patients with unresectable metastatic colorectal cancer: final survival analysis in the TASCO1 study

    Therapeutic options are limited in patients with unresectable metastatic colorectal cancer (mCRC) ineligible for intensive chemotherapy. The use of trifluridine/tipiracil plus bevacizumab (TT-B) in this settin...

    E. Van Cutsem, I. Danielewicz, M. P. Saunders, P. Pfeiffer in British Journal of Cancer (2022)

  3. Article

    Open Access

    Predictors of responses to immune checkpoint blockade in advanced melanoma

    Immune checkpoint blockers (ICB) have become pivotal therapies in the clinical armamentarium against metastatic melanoma (MMel). Given the frequency of immune related adverse events and increasing use of ICB, ...

    N. Jacquelot, M. P. Roberti, D. P. Enot, S. Rusakiewicz, N. Ternès in Nature Communications (2017)

  4. No Access

    Article

    Facteurs prédictifs et biomarqueurs précoces de réponse aux inhibiteurs de checkpoint immunologiques (anti-PD-1, anti-PD-L1)

    La compréhension de l’immunité antitumorale a conduit au développement clinique d’immunothérapies capables de bouleverser le pronostic des patients. L’identification précoce des patients qui tireront bénéfice ...

    E. Colle, T. Andre, C. Lebbe, C. Borg in Oncologie (2016)

  5. No Access

    Article

    Exposure to hypomethylating agent, 5-azacytidine, may improve iCasp9 suicide gene therapy for treating GvHD in allografts

    Anti-tumor cellular immunotherapies that implement a suicide gene system can limit potential undesirable effects. In a haplo-identical bone marrow transplant clinical trial, over 90% of iCaspase-9-expressing c...

    E Bôle-Richard, C Gamonet, J-M Certoux, I Idirene, F Larosa, E Deconinck in Gene Therapy (2016)

  6. No Access

    Article

    Expertise de la mémoire sémantique après une lésion cérébrale: le QMN

    Nous évaluons la capacité à définir des mots entrés dans le dictionnaire, en 1996–1997 et 2006–2007 (épreuves du questionnaire des mots nouveaux [QMN]), chez 12 patients cérébrolésés et 12 témoins. Les patient...

    C. Thomas-Antérion, C. Borg, A. Truche in La Lettre de médecine physique et de réada… (2009)

  7. No Access

    Article

    Sirolimus enhances the effect of apoptotic cell infusion on hematopoietic engraftment and tolerance induction

    F Bonnefoy, E Masson, S Perruche, A Marandin, C Borg, A Radlovic, B Shipman in Leukemia (2008)

  8. No Access

    Chapter

    CTLA-4 et Toll-like récepteurs: de nouvelles cibles en immunothérapie

    Plusieurs données cliniques suggèrent que la modulation des réponses immunitaires peut être une stratégie anti-tumorale efficace. Ládministration de BCG est reconnue comme un traitement efficace des cancers su...

    R. Bedel, C. Borg, P. Saas in Les thérapies ciblées (2008)

  9. No Access

    Chapter

    Hypothèses physiopathologiques dans les tumeurs épithéliales de l’ovaire

    C. Borg, E. Guardiola in Les cancers ovariens (2006)

  10. No Access

    Chapter

    Dendritic Cell-NK Cell Cross-Talk: Regulation and Physiopathology

    Dendritic cells (DC) are key players at the interface between innate resistance and cognate immunity. Recent evidence highlighted that innate effector cells can induce DC maturation, a checkpoint for the trigg...

    L. Zitvogel, M. Terme, C. Borg in Immunobiology of Natural Killer Cell Recep… (2006)

  11. No Access

    Chapter

    Mountain Birch Growth in Relation to Climate and Herbivores

    P. S. Karlsson, M. Weih, C. Borg in Plant Ecology, Herbivory, and Human Impact… (2005)

  12. Article

    Open Access

    Baseline and early lymphopenia predict for the risk of febrile neutropenia after chemotherapy

    A risk model for febrile neutropenia (FN) after conventional cytotoxic chemotherapy, based on early (day 5) lymphopenia and the dose of chemotherapy, has been described. A risk index based on parameters availa...

    I Ray-Coquard, C Borg, Th Bachelot, C Sebban, I Philip in British Journal of Cancer (2003)

  13. Article

    Open Access

    Identification of patients at risk for early death after conventional chemotherapy in solid tumours and lymphomas

    1–5% of cancer patients treated with cytotoxic chemotherapy die within a month after the administration of chemotherapy. Risk factors for these early deaths (ED) are not well known. The purpose of this study w...

    I Ray-Coquard, H Ghesquière, T Bachelot, C Borg, P Biron in British Journal of Cancer (2001)